Gaither K, Yue G, Singh D, Trudeau J, Ponraj K, Davydova N
J Xenobiot. 2025; 15(1).
PMID: 39997363
PMC: 11856820.
DOI: 10.3390/jox15010020.
Ponraj K, Gaither K, Singh D, Davydova N, Zhao M, Luo S
Biochem Pharmacol. 2024; 230(Pt 1):116569.
PMID: 39393643
PMC: 11609013.
DOI: 10.1016/j.bcp.2024.116569.
Gaither K, Singh D, Yue G, Trudeau J, Ponraj K, Davydova N
bioRxiv. 2024; .
PMID: 38798409
PMC: 11118358.
DOI: 10.1101/2024.05.14.594255.
Davydov D, Dangi B, Yue G, Ahire D, Prasad B, Zgoda V
Biomolecules. 2022; 12(2).
PMID: 35204686
PMC: 8869672.
DOI: 10.3390/biom12020185.
Chan L, Anderson G
Clin Pharmacokinet. 2014; 53(12):1115-36.
PMID: 25267448
DOI: 10.1007/s40262-014-0190-x.
Substantia nigra pars reticulata is crucially involved in barbiturate and ethanol withdrawal in mice.
Chen G, Kozell L, Buck K
Behav Brain Res. 2010; 218(1):152-7.
PMID: 20974184
PMC: 3075943.
DOI: 10.1016/j.bbr.2010.10.025.
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.
Miners J, Birkett D
Br J Clin Pharmacol. 1998; 45(6):525-38.
PMID: 9663807
PMC: 1873650.
DOI: 10.1046/j.1365-2125.1998.00721.x.
beta-blockers. Drug interactions of clinical significance.
Blaufarb I, Pfeifer T, Frishman W
Drug Saf. 1995; 13(6):359-70.
PMID: 8652080
DOI: 10.2165/00002018-199513060-00005.
Antiepileptic drugs. A review of clinically significant drug interactions.
Patsalos P, Duncan J
Drug Saf. 1993; 9(3):156-84.
PMID: 8240723
DOI: 10.2165/00002018-199309030-00003.
Age-related changes in the gastrointestinal system. Effects on drug therapy.
Iber F, Murphy P, Connor E
Drugs Aging. 1994; 5(1):34-48.
PMID: 7919638
DOI: 10.2165/00002512-199405010-00004.
Short-term ethanol administration impairs the elimination of chlordiazepoxide (Librium) in man.
Desmond P, Patwardhan R, Schenker S, Hoyumpa A
Eur J Clin Pharmacol. 1980; 18(3):275-8.
PMID: 7439248
DOI: 10.1007/BF00563011.
Pharmacokinetic interactions with antiepileptic drugs.
Perucca E
Clin Pharmacokinet. 1982; 7(1):57-84.
PMID: 7042173
DOI: 10.2165/00003088-198207010-00004.
Therapeutic drug monitoring of antiarrhythmic agents.
Brown J, SHAND D
Clin Pharmacokinet. 1982; 7(2):125-48.
PMID: 7039925
DOI: 10.2165/00003088-198207020-00003.
Drug interactions with phenytoin.
Perucca E, Richens A
Drugs. 1981; 21(2):120-37.
PMID: 7009138
DOI: 10.2165/00003495-198121020-00003.
Anticonvulsant drugs. An update.
Eadie M
Drugs. 1984; 27(4):328-63.
PMID: 6327221
DOI: 10.2165/00003495-198427040-00003.
Half-life of tolbutamide in patients with chronic respiratory failure.
SOTANIEMI E, Arvela P, Huhti E, Koivisto O
Eur J Clin Pharmacol. 1971; 4(1):29-31.
PMID: 5151390
DOI: 10.1007/BF00568895.
Drug metabolism and interaction with particular reference to the liver.
Cooksley W, Powell L
Drugs. 1971; 2(3):177-89.
PMID: 4947120
DOI: 10.2165/00003495-197102030-00001.
Enzyme induction and man.
Hunter J
Ir J Med Sci. 1974; 0(0):suppl:85-92.
PMID: 4851878
DOI: 10.1007/BF02938130.
Effects of ethanol on drug metabolism in the liver.
FALLON H, Liu S, Ramsey R
Trans Am Clin Climatol Assoc. 1973; 85:175-84.
PMID: 4804091
PMC: 2441333.
Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.
KUTT H, Louis S
Drugs. 1972; 4(3):256-82.
PMID: 4630143
DOI: 10.2165/00003495-197204030-00004.
